Gene Symbol | Gene ID | Gene Info |
---|---|---|
CUX2
|
ENSG00000111249.9 | cut like homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_111472240_111472468 | CUX2 | 526 | 0.832954 | 0.55 | 1.2e-01 | Click! |
chr12_111473052_111473203 | CUX2 | 1299 | 0.529942 | 0.55 | 1.3e-01 | Click! |
chr12_111471309_111471548 | CUX2 | 400 | 0.888834 | 0.53 | 1.4e-01 | Click! |
chr12_111471913_111472064 | CUX2 | 160 | 0.967122 | 0.49 | 1.8e-01 | Click! |
chr12_111549682_111549895 | CUX2 | 12538 | 0.235336 | -0.31 | 4.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_207094320_207094619 | 1.64 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
743 |
0.59 |
chr4_36244695_36244948 | 1.59 |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
740 |
0.5 |
chr10_6627562_6627792 | 1.56 |
PRKCQ |
protein kinase C, theta |
5414 |
0.34 |
chr14_61793878_61794206 | 1.54 |
PRKCH |
protein kinase C, eta |
411 |
0.85 |
chr2_68963054_68963510 | 1.51 |
ARHGAP25 |
Rho GTPase activating protein 25 |
1268 |
0.56 |
chr21_40139305_40139870 | 1.49 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
37644 |
0.21 |
chr7_50348888_50349341 | 1.47 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
796 |
0.76 |
chr12_118796743_118797337 | 1.47 |
TAOK3 |
TAO kinase 3 |
69 |
0.98 |
chr13_46755773_46755938 | 1.38 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
604 |
0.7 |
chr9_4285477_4285628 | 1.33 |
GLIS3 |
GLIS family zinc finger 3 |
12944 |
0.21 |
chr13_74806763_74806914 | 1.32 |
ENSG00000206617 |
. |
56513 |
0.16 |
chr3_152002678_152002963 | 1.26 |
MBNL1 |
muscleblind-like splicing regulator 1 |
14374 |
0.21 |
chr21_15917471_15917848 | 1.23 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
1003 |
0.63 |
chrX_12990488_12990859 | 1.22 |
TMSB4X |
thymosin beta 4, X-linked |
2554 |
0.33 |
chr13_84126063_84126363 | 1.20 |
ENSG00000222791 |
. |
253911 |
0.02 |
chr1_220527416_220527567 | 1.18 |
AC096644.1 |
Uncharacterized protein |
80532 |
0.09 |
chrX_78400540_78401325 | 1.18 |
GPR174 |
G protein-coupled receptor 174 |
25537 |
0.27 |
chr20_31099035_31099434 | 1.13 |
C20orf112 |
chromosome 20 open reading frame 112 |
24 |
0.98 |
chr20_49128549_49128700 | 1.12 |
PTPN1 |
protein tyrosine phosphatase, non-receptor type 1 |
1704 |
0.35 |
chr12_9822873_9823085 | 1.10 |
CLEC2D |
C-type lectin domain family 2, member D |
630 |
0.62 |
chr6_159464766_159465080 | 1.10 |
TAGAP |
T-cell activation RhoGTPase activating protein |
1127 |
0.51 |
chr17_30816627_30816809 | 1.09 |
CDK5R1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
1904 |
0.22 |
chr22_40298890_40299260 | 1.08 |
GRAP2 |
GRB2-related adaptor protein 2 |
1962 |
0.3 |
chr4_40209794_40209945 | 1.08 |
RHOH |
ras homolog family member H |
7905 |
0.22 |
chr1_55678186_55678720 | 1.07 |
USP24 |
ubiquitin specific peptidase 24 |
2309 |
0.34 |
chr12_54891959_54892179 | 1.07 |
NCKAP1L |
NCK-associated protein 1-like |
499 |
0.73 |
chr3_56832611_56832838 | 1.07 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
3253 |
0.36 |
chr1_198492691_198493057 | 1.07 |
ATP6V1G3 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
16930 |
0.28 |
chr5_28058907_28059058 | 1.06 |
ENSG00000221721 |
. |
72590 |
0.14 |
chr1_198609469_198609717 | 1.04 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
1301 |
0.54 |
chr17_33859992_33860143 | 1.04 |
SLFN12L |
schlafen family member 12-like |
4813 |
0.13 |
chr21_15917916_15918619 | 1.02 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
395 |
0.89 |
chr4_109084692_109084886 | 1.02 |
LEF1 |
lymphoid enhancer-binding factor 1 |
2668 |
0.31 |
chr14_22997550_22997780 | 1.01 |
TRAJ15 |
T cell receptor alpha joining 15 |
915 |
0.43 |
chr14_22966248_22966484 | 1.01 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
10195 |
0.1 |
chr12_8101164_8101417 | 1.00 |
SLC2A3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
12419 |
0.15 |
chr2_202127394_202127951 | 1.00 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
993 |
0.56 |
chr3_107845159_107845310 | 1.00 |
CD47 |
CD47 molecule |
35362 |
0.21 |
chr12_57077777_57078354 | 0.98 |
PTGES3 |
prostaglandin E synthase 3 (cytosolic) |
3881 |
0.14 |
chr3_187520878_187521148 | 0.98 |
BCL6 |
B-cell CLL/lymphoma 6 |
57498 |
0.14 |
chr8_29936071_29936255 | 0.98 |
TMEM66 |
transmembrane protein 66 |
3777 |
0.18 |
chr9_4865980_4866131 | 0.97 |
AL158147.2 |
HCG2011465; Uncharacterized protein |
6795 |
0.16 |
chrX_78202733_78203002 | 0.97 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
1949 |
0.5 |
chr14_92331424_92331867 | 0.96 |
TC2N |
tandem C2 domains, nuclear |
2228 |
0.32 |
chr3_163274827_163274978 | 0.96 |
ENSG00000265090 |
. |
40627 |
0.21 |
chr1_110046824_110047046 | 0.96 |
AMIGO1 |
adhesion molecule with Ig-like domain 1 |
5369 |
0.11 |
chr8_134086469_134086645 | 0.95 |
SLA |
Src-like-adaptor |
13954 |
0.23 |
chr14_71353925_71354621 | 0.95 |
PCNX |
pecanex homolog (Drosophila) |
19849 |
0.26 |
chrX_78620829_78620980 | 0.95 |
ITM2A |
integral membrane protein 2A |
1952 |
0.51 |
chr6_43082789_43082940 | 0.95 |
PTK7 |
protein tyrosine kinase 7 |
15465 |
0.11 |
chr8_29955696_29955905 | 0.94 |
LEPROTL1 |
leptin receptor overlapping transcript-like 1 |
2635 |
0.22 |
chr13_41589998_41590808 | 0.94 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
3047 |
0.26 |
chr22_40299734_40299885 | 0.93 |
GRAP2 |
GRB2-related adaptor protein 2 |
2696 |
0.25 |
chr18_77162823_77163056 | 0.93 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
2547 |
0.35 |
chr6_128239524_128239756 | 0.93 |
THEMIS |
thymocyte selection associated |
45 |
0.99 |
chr13_30510013_30510639 | 0.93 |
LINC00572 |
long intergenic non-protein coding RNA 572 |
9538 |
0.3 |
chr5_130603053_130603363 | 0.92 |
CDC42SE2 |
CDC42 small effector 2 |
3415 |
0.35 |
chr13_71667523_71667674 | 0.92 |
ENSG00000202433 |
. |
634002 |
0.0 |
chr14_71466281_71466432 | 0.91 |
PCNX |
pecanex homolog (Drosophila) |
13392 |
0.29 |
chr9_123687593_123687825 | 0.91 |
TRAF1 |
TNF receptor-associated factor 1 |
3338 |
0.27 |
chr1_98816414_98816565 | 0.91 |
ENSG00000221777 |
. |
22452 |
0.29 |
chr14_23011759_23011910 | 0.91 |
TRAJ15 |
T cell receptor alpha joining 15 |
13254 |
0.1 |
chr4_108642323_108642546 | 0.90 |
PAPSS1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
826 |
0.74 |
chr2_204572488_204572658 | 0.90 |
CD28 |
CD28 molecule |
1157 |
0.58 |
chr4_111437212_111437424 | 0.88 |
RP11-380D23.1 |
|
3343 |
0.3 |
chr14_99732558_99733007 | 0.88 |
AL109767.1 |
|
3497 |
0.26 |
chr13_41556565_41556847 | 0.88 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
288 |
0.92 |
chr6_128221625_128221781 | 0.87 |
THEMIS |
thymocyte selection associated |
400 |
0.91 |
chr15_81590989_81591168 | 0.87 |
IL16 |
interleukin 16 |
679 |
0.71 |
chr6_125401116_125401267 | 0.87 |
RNF217 |
ring finger protein 217 |
31833 |
0.2 |
chr1_1477179_1477330 | 0.87 |
TMEM240 |
transmembrane protein 240 |
1421 |
0.26 |
chr4_143321082_143321233 | 0.87 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
31255 |
0.26 |
chr1_101784802_101784953 | 0.87 |
RP4-575N6.5 |
|
76163 |
0.09 |
chr11_104941226_104941560 | 0.86 |
CARD16 |
caspase recruitment domain family, member 16 |
25290 |
0.15 |
chrX_30594869_30596024 | 0.85 |
CXorf21 |
chromosome X open reading frame 21 |
515 |
0.84 |
chr11_88068800_88069370 | 0.85 |
CTSC |
cathepsin C |
1816 |
0.49 |
chr8_38216839_38216990 | 0.85 |
WHSC1L1 |
Wolf-Hirschhorn syndrome candidate 1-like 1 |
21425 |
0.11 |
chr1_6087488_6087778 | 0.85 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
276 |
0.91 |
chr17_29639732_29640055 | 0.84 |
EVI2B |
ecotropic viral integration site 2B |
1209 |
0.36 |
chr8_124282051_124282202 | 0.84 |
ZHX1-C8ORF76 |
ZHX1-C8ORF76 readthrough |
2499 |
0.16 |
chr2_64441014_64441273 | 0.84 |
AC074289.1 |
|
7034 |
0.28 |
chr1_24513976_24514201 | 0.83 |
IFNLR1 |
interferon, lambda receptor 1 |
337 |
0.87 |
chr1_198613830_198613981 | 0.83 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
5613 |
0.26 |
chr21_29050610_29050761 | 0.83 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
711853 |
0.0 |
chr7_104908860_104909472 | 0.83 |
SRPK2 |
SRSF protein kinase 2 |
296 |
0.92 |
chr3_32996346_32996497 | 0.82 |
CCR4 |
chemokine (C-C motif) receptor 4 |
3355 |
0.33 |
chr12_25207113_25207806 | 0.81 |
LRMP |
lymphoid-restricted membrane protein |
1785 |
0.37 |
chr4_40202894_40203061 | 0.81 |
RHOH |
ras homolog family member H |
1013 |
0.59 |
chr5_72334540_72334691 | 0.81 |
ENSG00000200833 |
. |
61285 |
0.11 |
chr2_194347562_194347833 | 0.81 |
NA |
NA |
> 106 |
NA |
chr5_58055562_58056142 | 0.80 |
RP11-479O16.1 |
|
24754 |
0.24 |
chr7_142430441_142430617 | 0.80 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
26790 |
0.17 |
chr8_71287137_71287766 | 0.80 |
ENSG00000207036 |
. |
17869 |
0.21 |
chr4_109084210_109084462 | 0.80 |
LEF1 |
lymphoid enhancer-binding factor 1 |
3121 |
0.29 |
chr21_32553343_32553494 | 0.80 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
50879 |
0.17 |
chr2_45794731_45794926 | 0.79 |
SRBD1 |
S1 RNA binding domain 1 |
326 |
0.88 |
chr14_61799597_61799891 | 0.79 |
PRKCH |
protein kinase C, eta |
6113 |
0.21 |
chr3_32993381_32993532 | 0.79 |
CCR4 |
chemokine (C-C motif) receptor 4 |
390 |
0.9 |
chr6_24951057_24951285 | 0.78 |
FAM65B |
family with sequence similarity 65, member B |
14983 |
0.22 |
chr17_27137805_27137956 | 0.78 |
FAM222B |
family with sequence similarity 222, member B |
1362 |
0.23 |
chr7_7287223_7287567 | 0.78 |
C1GALT1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
13444 |
0.24 |
chr21_20465237_20465388 | 0.78 |
ENSG00000212609 |
. |
252153 |
0.02 |
chr14_102278905_102279056 | 0.78 |
CTD-2017C7.2 |
|
2322 |
0.22 |
chr6_154568354_154568864 | 0.78 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
53 |
0.99 |
chr1_198610198_198610371 | 0.77 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
1992 |
0.4 |
chr14_23038615_23038766 | 0.77 |
AE000662.93 |
|
12734 |
0.1 |
chr17_74750226_74750377 | 0.77 |
ENSG00000200257 |
. |
1307 |
0.26 |
chr12_42492275_42492426 | 0.77 |
ENSG00000222884 |
. |
18787 |
0.22 |
chr5_45697193_45697344 | 0.77 |
HCN1 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 1 |
1015 |
0.72 |
chr6_159235914_159236507 | 0.77 |
EZR-AS1 |
EZR antisense RNA 1 |
2833 |
0.23 |
chrX_78401406_78401924 | 0.77 |
GPR174 |
G protein-coupled receptor 174 |
24804 |
0.27 |
chr2_202098878_202099103 | 0.77 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
761 |
0.65 |
chr6_26403092_26403274 | 0.77 |
BTN3A1 |
butyrophilin, subfamily 3, member A1 |
660 |
0.54 |
chr12_71721523_71721674 | 0.77 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
111952 |
0.06 |
chr1_39681454_39681741 | 0.76 |
RP11-416A14.1 |
|
9413 |
0.17 |
chr6_6386490_6386781 | 0.76 |
F13A1 |
coagulation factor XIII, A1 polypeptide |
65389 |
0.13 |
chr3_111260963_111261300 | 0.76 |
CD96 |
CD96 molecule |
134 |
0.97 |
chr12_111471309_111471548 | 0.75 |
CUX2 |
cut-like homeobox 2 |
400 |
0.89 |
chr14_55799126_55799413 | 0.75 |
RP11-665C16.5 |
|
6950 |
0.25 |
chrX_70328307_70328586 | 0.75 |
IL2RG |
interleukin 2 receptor, gamma |
672 |
0.51 |
chr10_15873436_15873587 | 0.75 |
FAM188A |
family with sequence similarity 188, member A |
5787 |
0.29 |
chr7_150413396_150413547 | 0.75 |
GIMAP1 |
GTPase, IMAP family member 1 |
174 |
0.94 |
chr15_59981781_59982063 | 0.75 |
BNIP2 |
BCL2/adenovirus E1B 19kDa interacting protein 2 |
189 |
0.9 |
chr3_112693608_112694254 | 0.74 |
CD200R1 |
CD200 receptor 1 |
6 |
0.97 |
chr1_32721190_32721341 | 0.74 |
LCK |
lymphocyte-specific protein tyrosine kinase |
4390 |
0.1 |
chr10_7793124_7793275 | 0.74 |
KIN |
KIN, antigenic determinant of recA protein homolog (mouse) |
36745 |
0.14 |
chr1_205425124_205425391 | 0.74 |
LEMD1 |
LEM domain containing 1 |
6198 |
0.17 |
chr7_21472009_21472160 | 0.74 |
SP4 |
Sp4 transcription factor |
4423 |
0.22 |
chr14_99729127_99729416 | 0.74 |
AL109767.1 |
|
14 |
0.98 |
chr2_69002223_69002932 | 0.74 |
ARHGAP25 |
Rho GTPase activating protein 25 |
505 |
0.84 |
chrX_31453419_31453570 | 0.74 |
ENSG00000252903 |
. |
87185 |
0.1 |
chr10_105670292_105670878 | 0.74 |
OBFC1 |
oligonucleotide/oligosaccharide-binding fold containing 1 |
6842 |
0.18 |
chr14_53208430_53208600 | 0.74 |
STYX |
serine/threonine/tyrosine interacting protein |
11615 |
0.15 |
chrX_12990257_12990408 | 0.73 |
TMSB4X |
thymosin beta 4, X-linked |
2895 |
0.31 |
chr6_25405502_25405752 | 0.73 |
ENSG00000253017 |
. |
2496 |
0.27 |
chr13_49136021_49136172 | 0.73 |
RCBTB2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
28727 |
0.23 |
chr13_99857558_99857709 | 0.73 |
ENSG00000201793 |
. |
329 |
0.88 |
chr7_100140182_100140395 | 0.73 |
AGFG2 |
ArfGAP with FG repeats 2 |
3406 |
0.11 |
chr2_139740607_139740758 | 0.72 |
ENSG00000222826 |
. |
119217 |
0.07 |
chr18_29601411_29601562 | 0.72 |
RNF125 |
ring finger protein 125, E3 ubiquitin protein ligase |
3151 |
0.21 |
chr2_214004488_214004639 | 0.72 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
8790 |
0.3 |
chr13_105637174_105637325 | 0.72 |
DAOA |
D-amino acid oxidase activator |
481343 |
0.01 |
chr12_26399329_26399480 | 0.72 |
RP11-283G6.5 |
|
25351 |
0.18 |
chr6_106547367_106547905 | 0.72 |
RP1-134E15.3 |
|
379 |
0.74 |
chr20_57234804_57234955 | 0.71 |
STX16 |
syntaxin 16 |
7697 |
0.17 |
chr3_73031631_73031782 | 0.71 |
PPP4R2 |
protein phosphatase 4, regulatory subunit 2 |
14230 |
0.18 |
chr2_213983567_213983718 | 0.71 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
29711 |
0.24 |
chr15_96817385_96817602 | 0.71 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
1732 |
0.37 |
chr14_22980644_22980795 | 0.71 |
TRAJ15 |
T cell receptor alpha joining 15 |
17861 |
0.09 |
chr12_117535875_117536067 | 0.70 |
TESC |
tescalcin |
1280 |
0.57 |
chr3_151973155_151973306 | 0.70 |
MBNL1 |
muscleblind-like splicing regulator 1 |
12599 |
0.22 |
chrX_57314086_57314237 | 0.70 |
FAAH2 |
fatty acid amide hydrolase 2 |
1022 |
0.69 |
chr16_74634832_74635106 | 0.70 |
GLG1 |
golgi glycoprotein 1 |
6023 |
0.24 |
chr3_43430810_43431075 | 0.70 |
SNRK-AS1 |
SNRK antisense RNA 1 |
37488 |
0.15 |
chr15_90735520_90735720 | 0.70 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
460 |
0.74 |
chr9_22668028_22668179 | 0.70 |
DMRTA1 |
DMRT-like family A1 |
221263 |
0.02 |
chr4_90408760_90409167 | 0.70 |
RP11-115D19.1 |
|
63544 |
0.15 |
chr13_74807691_74807851 | 0.69 |
ENSG00000206617 |
. |
55580 |
0.16 |
chr11_82828119_82828301 | 0.69 |
PCF11 |
PCF11 cleavage and polyadenylation factor subunit |
39820 |
0.12 |
chr14_22980147_22980432 | 0.69 |
TRAJ15 |
T cell receptor alpha joining 15 |
18291 |
0.09 |
chr17_29645805_29646348 | 0.69 |
CTD-2370N5.3 |
|
227 |
0.88 |
chrX_154493044_154493313 | 0.69 |
RAB39B |
RAB39B, member RAS oncogene family |
696 |
0.67 |
chr11_98660793_98660944 | 0.68 |
CNTN5 |
contactin 5 |
231003 |
0.02 |
chr12_47610316_47610761 | 0.68 |
PCED1B |
PC-esterase domain containing 1B |
157 |
0.96 |
chr17_76670239_76670390 | 0.68 |
ENSG00000252391 |
. |
22565 |
0.18 |
chr2_102974215_102974435 | 0.67 |
IL18R1 |
interleukin 18 receptor 1 |
1936 |
0.32 |
chr2_113065761_113065912 | 0.67 |
ZC3H6 |
zinc finger CCCH-type containing 6 |
32658 |
0.16 |
chr6_90903910_90904061 | 0.67 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
102476 |
0.07 |
chr5_74965499_74965780 | 0.67 |
ENSG00000207333 |
. |
39785 |
0.14 |
chr12_4384723_4384874 | 0.67 |
CCND2 |
cyclin D2 |
432 |
0.41 |
chr5_118674167_118674322 | 0.67 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
5374 |
0.23 |
chr21_42493311_42493462 | 0.67 |
LINC00323 |
long intergenic non-protein coding RNA 323 |
25964 |
0.16 |
chr6_106809590_106809741 | 0.67 |
RP11-404H14.1 |
|
2073 |
0.31 |
chr14_22992275_22992426 | 0.67 |
TRAJ15 |
T cell receptor alpha joining 15 |
6230 |
0.12 |
chr11_118176160_118176414 | 0.67 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
673 |
0.59 |
chr14_58711962_58712794 | 0.66 |
PSMA3 |
proteasome (prosome, macropain) subunit, alpha type, 3 |
756 |
0.54 |
chr16_68503734_68504345 | 0.66 |
ENSG00000199263 |
. |
4528 |
0.18 |
chr1_160614614_160614765 | 0.66 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
2122 |
0.27 |
chr5_119820967_119821118 | 0.66 |
PRR16 |
proline rich 16 |
19716 |
0.29 |
chr10_33234705_33234856 | 0.66 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
9601 |
0.29 |
chr2_109230989_109231140 | 0.66 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
6658 |
0.25 |
chr3_28133741_28133892 | 0.66 |
CMC1 |
C-x(9)-C motif containing 1 |
149270 |
0.04 |
chr6_37484799_37485050 | 0.66 |
CCDC167 |
coiled-coil domain containing 167 |
17226 |
0.19 |
chr11_67478742_67478899 | 0.66 |
ENSG00000266451 |
. |
23259 |
0.12 |
chr8_10981801_10982129 | 0.66 |
AF131215.3 |
|
1609 |
0.27 |
chr4_68410033_68410229 | 0.66 |
CENPC |
centromere protein C |
1193 |
0.53 |
chrX_33573585_33573736 | 0.66 |
DMD |
dystrophin |
216102 |
0.02 |
chr1_192776419_192777001 | 0.65 |
RGS2 |
regulator of G-protein signaling 2, 24kDa |
1461 |
0.52 |
chr4_109086470_109087224 | 0.65 |
LEF1 |
lymphoid enhancer-binding factor 1 |
610 |
0.72 |
chr6_48087052_48087203 | 0.65 |
PTCHD4 |
patched domain containing 4 |
50702 |
0.19 |
chr7_150414678_150414897 | 0.65 |
GIMAP1 |
GTPase, IMAP family member 1 |
1142 |
0.45 |
chr1_198734901_198735052 | 0.65 |
ENSG00000207975 |
. |
93135 |
0.08 |
chr3_183271904_183272141 | 0.65 |
KLHL6 |
kelch-like family member 6 |
1455 |
0.38 |
chr16_84766778_84766973 | 0.64 |
USP10 |
ubiquitin specific peptidase 10 |
33229 |
0.16 |
chr6_27058062_27058213 | 0.64 |
ENSG00000222800 |
. |
19622 |
0.13 |
chr12_40076492_40076709 | 0.64 |
C12orf40 |
chromosome 12 open reading frame 40 |
56615 |
0.14 |
chr22_45933014_45933165 | 0.64 |
FBLN1 |
fibulin 1 |
18426 |
0.2 |
chr14_23005213_23005364 | 0.64 |
TRAJ15 |
T cell receptor alpha joining 15 |
6708 |
0.11 |
chr6_82470488_82470639 | 0.64 |
ENSG00000206886 |
. |
3178 |
0.26 |
chr9_84437486_84437637 | 0.64 |
ENSG00000263404 |
. |
16565 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.5 | 1.4 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.4 | 1.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 1.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.3 | 1.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 2.9 | GO:0043383 | negative T cell selection(GO:0043383) |
0.3 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.7 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.5 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.3 | 1.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 2.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 1.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 1.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.3 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.2 | 0.5 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.2 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.3 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.4 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 2.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.4 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.5 | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 4.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 1.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 1.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 1.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 1.2 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.0 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 1.0 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 1.0 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.2 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 1.5 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.0 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.8 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.1 | GO:0048670 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0045409 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.7 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.0 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 1.4 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.8 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0060045 | positive regulation of cardiac muscle tissue growth(GO:0055023) positive regulation of cardiac muscle tissue development(GO:0055025) positive regulation of cardiac muscle cell proliferation(GO:0060045) positive regulation of heart growth(GO:0060421) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0060253 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.0 | 0.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.1 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.2 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 5.5 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 1.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 1.3 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.3 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.7 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.3 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.0 | 0.1 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.0 | 0.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 2.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.2 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.5 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.0 | 0.0 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 1.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.3 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.2 | GO:0000084 | mitotic S phase(GO:0000084) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.6 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:1903008 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) organelle disassembly(GO:1903008) |
0.0 | 0.0 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0090502 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA 5'-end processing(GO:0000966) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.7 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.2 | GO:2001057 | nitric oxide metabolic process(GO:0046209) reactive nitrogen species metabolic process(GO:2001057) |
0.0 | 0.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.2 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.0 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.0 | GO:0003417 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.5 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.8 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 2.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.4 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 4.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 2.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 2.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.6 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 1.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0017136 | histone deacetylase activity(GO:0004407) NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) protein deacetylase activity(GO:0033558) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 3.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 3.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.3 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 1.0 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 1.5 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 1.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 1.0 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.3 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 2.7 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 1.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 3.1 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 3.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.4 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 5.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 3.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 2.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 2.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |